trending Market Intelligence /marketintelligence/en/news-insights/trending/ss8uacl2f9tu9mhy4w73zw2 content esgSubNav
In This List

MYM Nutraceuticals appoints chief science officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


MYM Nutraceuticals appoints chief science officer

MYM Nutraceuticals Inc. appointed Charith Adkar as chief science officer, effective March 7.

Adkar's areas of expertise include plant science, biotechnology, microbiology, molecular host-pathogen interactions and bioinformatics.

Vancouver, British Columbia-based MYM Nutraceuticals produces medicinal cannabis supplements and topical products.